Thirty Madison raises $47 million for its direct to customer treatments of loss of hair, migraines and indigestion
Thirty Madison, the New York-based start-up establishing a series of direct to consumer treatments for loss of hair, migraines and persistent indigestion, has actually raised$47 million in new financing. After last week’s almost$19 billion merger in between Teladoc and Livongo, remote therapies and virtual care business are all the rage amongst the health care market, and Thirty […]
After last week’s nearly$19 billion merger between Teladoc and Livongo, remote treatments and virtual care companies are all the rage among the healthcare industry, and Thirty Madison’s company is no exception. Returned to back the company in an offer led by Polaris Partners. That, paired with the more narrow focus on a couple of particular conditions, differentiate Thirty Madison from its peers in the industry….